Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Should Investors Expect When Bridger Aerospace (NASDAQ:BAER) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Kyntra Bio, Inc. (NASDAQ:KYNB) Reports Q3 2026 Results on November 16, 2026?

In the quarter ended June 30, 2026, totalRevenuewas negative USD 1.5 million, reflecting drug product revenue of negative USD 1.577 million, against USD 1.3 million a year earlier. Loss from operations widened to USD 17.6 million from USD 12.1 million and interest expense was …

Vinay Lochav | 13 November 2026

What Should Investors Expect When ClearSign Technologies (NASDAQ:CLIR) Reports on November 19, 2026 With EPS Estimate -0.20?

The Rationale: Last Reported Quarter and Management Outlook for ClearSign Technologies Corporation (NASDAQ:CLIR)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Daré Bioscience (NASDAQ:DARE) Reports on November 16, 2026 With EPS Estimate -0.13?

For the quarter ended June 30, 2026, totalRevenuewas USD 187,546, compared with negative USD 21,172 a year earlier, with cost of revenues of USD 319,889. Selling, general and administrative expense was USD 2,593,671, while research and development expense, net of grant offsets of about …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Getty Images Holdings (OTC:GETY) Reports Q3 2026 Results on November 16, 2026?

In the second quarter of 2026 revenue was USD 229.1 million, down 4.1% on a currency neutral basis. Creative revenue was USD 127.4 million and other revenue fell to USD 5.2 million from USD 15.7 million. Annual Subscription revenue reached 58.8% of the total, …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Lantern Pharma (NASDAQ:LTRN) Reports Q3 2026 Results on November 16, 2026?

The second quarter of 2026 showed lower operating spending. Research and development expense was USD 1.8 million against USD 3.1 million, general and administrative expense rose 8% to USD 1.7 million from USD 1.6 million, and the loss from operations was USD 3.5 million. …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Data Storage Corporation (NASDAQ:DTST) Reports Q3 2026 Results on November 16, 2026?

Key Highlights358,530 is the USD in sales reported by Data Storage Corporation (NASDAQ:DTST) for the second quarter of 2026, up 9.3% from USD 327,951 a year earlier, withGross Profitrising to USD 168,481 from USD 138,182.9.3 million is the USD held in cash, cash equivalents …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Aqua Metals (NASDAQ:AQMS) Reports Q3 2026 Results on November 16, 2026?

Second quarter operating expenses were USD 4,594 thousand against USD 7,031 thousand a year earlier, including a provision forCreditlosses of USD 2,059 thousand and general and administrative expense of USD 1,723 thousand. Management gives no formal financial guidance and framed its outlook as priorities …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Skye Bioscience (NASDAQ:SKYE) Reports Q3 2026 Results on November 16, 2026?

The operating loss was USD 11.1 million in the second quarter and USD 23.7 million for six months. Research and development expense was USD 3.9 million, down 73% year over year, and USD 11.9 million for six months, down 45%. Management expects significant losses …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Vivos Therapeutics (NASDAQ:VVOS) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Vivos Therapeutics, Inc. (NASDAQ:VVOS)

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…